IGF2BP2 Regulates the Progression of Alzheimer's Disease Through m6A‐Mediated NLRP3 Inflammasome
ABSTRACT Background Recent studies show that N6‐methyladenosine (m6A) plays an important role in the pathogenesis of the Alzheimer's disease (AD), while the mechanisms involved were studied insufficiently. Aims The present study aimed to explore the effect of human insulin‐like growth factor 2...
Saved in:
Main Authors: | Wu Jingrui, Yang Haihui, Yan Jinjin, Fang Le |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Immunity, Inflammation and Disease |
Subjects: | |
Online Access: | https://doi.org/10.1002/iid3.70121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-cancer characterization of m6A-mediated regulation of T cell exhaustion dynamics and clinical relevancies in human cancers
by: Weiping Ji, et al.
Published: (2025-03-01) -
Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner
by: Dan-dan Xiong, et al.
Published: (2025-02-01) -
Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC
by: Yulin Zhang, et al.
Published: (2025-02-01) -
Multi-omics reveals that ST6GAL1 promotes colorectal cancer progression through LGALS3BP sialylation
by: Yuanchao Shi, et al.
Published: (2025-02-01) -
C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
by: Xiaoting Luo, et al.
Published: (2025-02-01)